Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bristol-Myers Squibb Company (BMY)
:BMY
Holding BMY?
Track your performance easily
Bristol-Myers Squibb (BMY) Ownership Overview
0.07% Insiders
21.55% Mutual Funds
0.50% Other Institutional Investors
23.18% ETFs
54.70% Public Companies and Individual Investors
The ownership structure of Bristol-Myers Squibb (BMY) stock is a mix of institutional, retail, and individual investors. Approximately 45.23% of the company’s stock is owned by Institutional Investors, 0.07% is owned by Insiders, and 54.70% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 05, 2024 | Phil M Holzer Svp & Controller | xxxxxxxxxxxxx | $38927 |
| Nov 05, 2024 | Samit Hirawat Evp,chief Med.offr.,drug Dev | xxxxxxxxxxxxx | $100046 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $203079 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $495824 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1112047 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1267474 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 156,566,652 | Institution | 7.72% | 8,753,641,513 | |
| 136,837,921 | Institution | 6.75% | 7,650,608,163 | |
| 80,381,990 | Institution | 3.96% | 4,494,157,061 | |
| 77,256,560 | Institution | 3.81% | 4,319,414,270 | |
| 53,376,301 | Institution | 2.63% | 2,984,268,989 | |
| 33,644,940 | Institution | 1.66% | 1,881,088,595 | |
| 23,369,570 | Institution | 1.15% | 1,306,592,659 | |
| 18,007,799 | Institution | 0.89% | 1,006,816,042 | |
| 16,461,475 | Institution | 0.81% | 920,361,067 | |
| 15,627,743 | Institution | 0.77% | 873,747,111 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 136,837,921 | Institution | 6.75% | 7,650,608,163 | |
| 33,644,940 | Institution | 1.66% | 1,881,088,595 | |
| 16,461,475 | Institution | 0.81% | 920,361,067 | |
| 14,050,207 | Institution | 0.69% | 785,547,073 | |
| 12,726,086 | Institution | 0.63% | 711,515,468 | |
| 11,822,839 | Institution | 0.58% | 661,014,928 | |
| 10,593,542 | Institution | 0.52% | 592,284,933 | |
| 10,367,907 | Institution | 0.51% | 579,669,680 | |
| 9,812,178 | Institution | 0.48% | 548,598,872 | |
| 9,128,729 | Institution | 0.45% | 510,387,238 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 63,742,072 | Institution | 3.14% | 3,774,805,504 | |
| 54,511,532 | Institution | 2.69% | 3,228,172,925 | |
| 47,540,454 | Institution | 2.34% | 2,649,904,906 | |
| 25,239,296 | Institution | 1.24% | 1,411,129,039 | |
| 25,208,278 | Institution | 1.24% | 1,405,109,416 | |
| 23,813,564 | Institution | 1.17% | 1,331,416,363 | |
| 17,341,364 | Institution | 0.86% | 1,026,955,576 | |
| 14,955,570 | Institution | 0.74% | 833,623,472 | |
| 8,878,610 | Institution | 0.44% | 494,893,721 | |
| 8,464,417 | Institution | 0.42% | 471,806,604 |
FAQ
Who Owns Bristol-Myers Squibb Company (BMY)?
According to the latest TipRanks data, approximately 0.50% of the company's stock is held by institutional investors, 0.07% is held by insiders, and 54.70% is held by retail investors.
What percentage of Bristol-Myers Squibb Company (BMY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.50% of Bristol-Myers Squibb Company (BMY) stock is held by institutional investors.
What percentage of Bristol-Myers Squibb Company (BMY) stock is held by retail investors?
According to the latest TipRanks data, approximately 54.70% of Bristol-Myers Squibb Company (BMY) stock is held by retail investors.
Who owns the most shares of Bristol-Myers Squibb Company (BMY)?
Vanguard owns the most shares of Bristol-Myers Squibb Company (BMY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.